| Abstrakt: |
B. Salence, Z. Askham, W. Perkins and S. Ziaj I Oxford University Hospitals NHS Foundation Trust, Oxford, UK i According to the 2020 UK Service guidance and standards for Mohs micrographic surgery (MMS), MMS should be considered for basal cell carcinoma (BCC) with aggressive histology and particularly for those in high-risk anatomical sites (the H zone). BCC recurrence was seen by most surgeons following MMS when additional treatments had been used for the residual superficial disease ( I n i = 22; 73%). [Extracted from the article] |
Plný text